IVIM Health vs Luvo Health: pricing, reviews, and program differences

Comparing IVIM Health vs Luvo Health quickly: IVIM supplies clear starting prices, a GIFT75 free-month offer and dual 4.9-star third-party ratings, while Luvo Health’s captured landing page shows clinician-reviewed programs but does not publish verifiable pricing or ratings. Early verdict: IVIM is stronger on published pricing and external ratings; Luvo requires confirming eligibility, cost and state availability before enrolling.

How the two providers differ at a glance

IVIM Health vs Luvo Health stands out across a few clear, supported differences: published pricing and promo availability, third-party ratings and study claims, clarity on compounded medication status and program details, and what the captured pages disclose about cancellations and ongoing support.

1. Pricing transparency and promotional offers

IVIM Health: Captured evidence lists specific prices: semaglutide (compounded) at $75/mo, tirzepatide (compounded) at $133/mo plus a $74.99/mo program fee, and public FAQ text noting $99 first month and $174/month ongoing; IVIM also advertises a Free Month Membership with code GIFT75 and a no-obligation free consultation valued at $75. Luvo Health: The captured landing page did not publish verifiable starting prices; it shows month-by-month phrasing (MONTH 1, MONTH 2–3, 3+ MONTHS) and says users should confirm cost and eligibility with the live offer.

Check Luvo Health eligibility and live offer

2. Third-party ratings and outcome claims

IVIM Health: The source repeatedly highlights a 4.9-star rating on both Google and Trustpilot and promotes a proprietary GLP-1 ID protocol that the company says may accelerate weight loss up to 40% faster; IVIM also references published observational outcome studies and an internal published comparison claiming an average of 46% more weight loss over 68 weeks versus a separate published GLP-1 trial, with repeated qualifiers that this is not a head-to-head study. Luvo Health: The captured landing page did not supply third-party ratings or published outcome claims in the captured evidence and therefore these details are not verified by the source.

3. Medication formulation and regulatory notes

Both providers’ captured materials show compounded formulations may be offered and include the regulatory note that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. IVIM explicitly states its offerings include compounded semaglutide and compounded tirzepatide and emphasizes clinician supervision; Luvo’s captured page lists tirzepatide injection, semaglutide injection and tablets, and notes compounded medications, when offered, are not FDA-approved and are provided only when a clinician determines treatment is appropriate.

4. Program structure, clinician review and cancellation

IVIM emphasizes a clinician-guided GLP-1 ID titration protocol, weekly dose adjustments and a clinician evaluation before Rx, and it states the free consultation is no-obligation. The captured Luvo page emphasizes ongoing support, dose changes, and that treatment is available only when a licensed clinician determines it is medically appropriate. Luvo’s captured evidence also includes a cancel-anytime indication but did not publish full pricing, state coverage or renewal terms in the capture; the source warns these details may change and should be confirmed live.

Side-by-side comparison

What the captured evidence does not show

The Luvo Health capture did not publish verified starting prices, third-party ratings or peer-reviewed study claims in the captured landing page, so those items must be confirmed with Luvo directly. Neither source’s capture supplies comprehensive safety, side-effect rates or insurance coverage details beyond the provided qualifiers.

Bottom line and who should choose which provider

IVIM Health vs Luvo Health compares most clearly on published pricing and external ratings versus a more opaque captured Luvo landing page. IVIM supplies specific starting prices, a GIFT75 free month code, a free no-obligation consult and dual 4.9-star ratings in the captured evidence, plus company-published protocol and observational study claims with repeated qualifiers. Luvo’s captured page emphasizes clinician review, ongoing support and dose adjustments but did not publish verified pricing or ratings in the captured evidence and advises confirming eligibility, cost and state availability with the live offer.

Confirm Luvo Health live pricing and state availability

Choose IVIM Health if you prioritize published starting prices, a GIFT75 free-month option, a no-obligation $75-valued consult and third-party ratings in the captured evidence. Choose Luvo Health if you need a clinician-reviewed enrollment path and will confirm live eligibility, exact pricing, renewal terms and state availability before enrolling. For the IVIM Health vs Luvo Health comparison, use the captured source details above to verify any remaining questions directly with each provider.